Summary 14 15
The integration of biochemistry into immune cell biology has immensely contributed to our 16 understanding of immune cell function and the associated pathologies. So far, most studies have 17 focused on the regulation of metabolic pathways during an immune response and their contribution 18 to its success. More recently, novel signalling functions of metabolic intermediates are being 19 discovered that might play important roles in the regulation of immunity. Here, we describe the 20 three long-known small metabolites lactate, acetyl-CoA and succinate in the context of immuno-21 metabolic signalling. Functions of these ubiquitous molecules are largely dependent on their intra-22
and extra-cellular concentrations as well as their sub-compartmental localization. Importantly, the 23 signalling functions of these metabolic intermediates extend beyond self-regulatory roles and 24 include cell to cell communication and sensing of micro-environmental conditions to elicit stress 25 responses and cellular adaptation. 26 27 Metabolite signaling in immunity 28
29
The metabolic regulation of immune cells during health and disease has gained a lot of 30 attention as the active reconfiguration of immune cell metabolism enables these cells to sustain 31 certain effector functions. The focus so far has been on the necessity of the main catabolic pathways 32 glycolysis, fatty acid oxidation, the anaplerotic tricarboxylic acid (TCA) cycle and oxidative 33 phosphorylation as well as amino acid metabolism ( Figure 1 ) during activation, proliferation, 34 differentiation and function as a response to extracellular signals. 35
It is now becoming increasingly evident that small molecule intermediates of these 36 metabolic pathways, besides their anabolic and catabolic function, can act as intra-and extracellular 37 signals that influence the outcome of an immune response. The roles of metabolite signalling stretch 38 from regulation of cytokine production via indirect effects on the cellular redox state [1] or direct 39 interaction with transcription factors binding the specific cytokine promoter elements [2] and 40 modulating the activity of transmembrane ion channels [3] , to interference with cell migration and 41 differentiation. Interestingly, a few G-protein coupled receptors that are activated by intermediates 42 of metabolism have recently been identified supporting a role for metabolites as extracellular signals 43 [4, 5] . In this review, we discuss the three well known metabolites lactate, succinate and acetyl-CoA 44 in more detail; identify their differences and similarities in signal transduction and effect on 45 immunity and inflammation that defines them as novel signalling molecules in physiology and 46 pathology. 47 48
Lactate is a signalling molecule 49
Lactate is a ubiquitous molecule, whose presence in the mammalian body was first observed 51 in muscle tissue at the beginning of the 19 th century [6] . Since its discovery, lactate has been 52 intensely studied and it has been shown to have numerous metabolic functions (Figure 2 , Key 53 Figure) , including as a central metabolite in the Cori cycle (also known as the lactic acid cycle), which 54 mediates metabolic cross talk between the liver and the muscle. In the Cori cycle, muscle tissue 55 metabolizes liver-derived glucose to lactate, which in turn is shuttled back to the liver and acts as a 56 fuel source for hepatic gluconeogenesis [7] . By contrast, in the brain lactate acts as a metabolic 57 signal and fuel for oxidative metabolism, which is the basis of the neuron-astrocyte lactate shuttle 58 [8] . Briefly, the neurotransmitter glutamate induces high glycolytic activity in astrocytes, which 59 secrete lactate into the synaptic cleft. The increased availability of extracellular lactate enables 60 neurons to import it and use it as an alternative fuel source. 61
Although lactate has been known to biochemists for over two hundred years, it has been 62 long neglected, seen as a by-product or a bio-marker at best rather than a bio-active molecule. As a 63 consequence its potential functional effects have been under appreciated. 64
Recently, lactate is being rediscovered as an active signalling metabolite in multiple fields of 65 biology and medicine that has two main ways of signal transduction -transporter and receptor 66 mediated. Its direct regulation of global gene transcription [9, 10], endothelial and cancer cell 67 migration [11, 12] , cancer progression [13] and functional polarization of immune cells are being 68 described [14] [15] [16] . 69
Lactate production occurs mainly in the cytoplasm during hypoxia or aerobic glycolysis in 70 proliferative cells and is then secreted through the plasma membrane. This transport is dependent 71 on six so far described solute carrier transporters that perform proton -lactate symport (Mct1-4) or 72 a sodium-dependent symport (Slc5a8, Slc5a12) [17, 18] The physiological lactate concentration is about 1.5mM -3mM [18] in blood and healthy 82 tissues, but can rise up to 10mM in inflammatory pathologies such as atherosclerotic plaques or 83 rheumatic synovial fluid and even up to 20-30mM in cancerous tissue [14, 15, 20] . Far from being 84 inert, accumulating lactate -a feature of most inflammatory sites -has tremendous effects on 85 tissue resident or infiltrating immune cells as well as stromal cells. In the tumour microenvironment, 86 lactate produced by tumour cells is taken up by macrophages where it promotes polarization 87 towards Arginase 2 (Arg2) expressing M2-like phenotype via Hypoxia inducible factor 1α (Hif-1α) 88 stabilization and the resulting increased production of vascular endothelial growth factor (VEGF). 89
These effects further enhance tumour growth in a vicious loop [14] . The authors applied unbiased 90 high-throughput platforms to look for hypothetical protein factors perpetuating such vicious loop, 91 but surprisingly found lactate as the orchestrating factor. Similarly, an independent study recently 92 found lactate to be the driving force behind tumour associated macrophage (TAM) development 93 during epithelial to mesenchymal transition [16] . 94
The involvement of Hif-1α in the response to lactate is currently under scrutiny. On the one 95
hand, it has been demonstrated that targeting the lactate transporter Mct1 in endothelial cells or 96 cervix squamous carcinoma cells rescues lactate-mediated Hif-1α activation and inhibits the 97 consequential angiogenesis [21, 22] . On the other hand, these authors could show a lactate 98 mediated Hif-1α independent induction of angiogenesis. Here, reactive oxygen species (ROS) 99 induced the NF-κB pathway that led to IL-8 expression, a known chemotactic molecule that resulted 100 in increased cell migration and tumour metastasis [23] . Additionally, a recent study demonstrates 101 the Hif-1α independent, direct binding of lactate to NDRG3 during hypoxia. Upon lactate binding, 102 NDRG3 is stabilized and executes a Raf-ERK1/2 mediated signalling cascade promoting angiogenesis 103 and cell growth [24] . Surprisingly, not only migration-promoting but also inhibiting functions of 104 lactate have been described. 105 Activated T cells that infiltrate inflammatory sites are exposed to the increased lactate 106 concentration that is commonly found in these sites (e.g., 10-12mM in arthritic synovium) [15] . Due 107 to the high extracellular concentration, lactate internalization through the CD8 + T cell specific 108 In addition, lactate also triggers the production of the pro-inflammatory cytokine IL-17 in the 118 CD4 + subset and inhibits the cytolytic function of cytotoxic CD8 + T cells (CTL) ( Figure 2 ). The observed 119 inhibition of CTL function was also reported in an earlier publication, showing that both proliferation 120 and cytokine production in human CTLs is severely impaired in the presence of lactic acid [26] . 121
The observed effects of T cell entrapment, CTL inhibition and increased production of pro-122 inflammatory cytokines are common features of many chronic inflammatory diseases that might be 123 Contrarily, the effects on glycolysis remain questionable. It was shown that 10mM 149 extracellular lactate inhibits glycolytic activity in T cells, which could be facilitated by downregulation 150 of hexokinase 1 or direct inhibition of phosphofructokinase. By contrast, in heart tissue lactate 151 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64 causes increased Glut1 and Glut4 expression on the plasma membrane, which is in general an 152 indicator of increased glucose uptake and flux [38] . 153
Taken together, lactate-induced signalling is an important pathway in health and disease. As 154 discussed here, lactate has two primary means of relaying signals into the cell (receptor-and 155 transporter-mediated), and lactate signalling has several possible outcomes that depend on the cell 156 type. Moreover, the concentration of extracellular lactate that lie between 1.5mM in physiological 157 and 10-30mM in pathological settings has immense impact on cell function as it will lead to the 158 activation of different signalling pathways. For the rest of this section we focus on succinate, as in the past few years it has been 176 reported to be a central metabolite in the biology of immune cells (such as macrophages) as well as 177 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62 3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64 regard to M1 polarization, they identified two TCA cycle break-points: the first at the conversion 204 point of citrate to α-ketoglutarate, and the second after succinate synthesis at the conversion point 205 of succinate to fumarate. The first break-point, due to the downregulation of isocitrate 206 dehydrogenase, results in citrate accumulation, which is then redirected towards production of 207 itaconic acid, an anti-microbial metabolite [51]. The authors also described a second break-point, at 208 the TCA step of converting succinate into fumarate; succinate accumulation increased, as previously 209 reported [2]. Despite the low efficiency of succinate to fumarate conversion, an accumulation of 210 malate (produced from fumarate) was also observed. This was due to the upregulation of the 211 arginosuccinate shunt, a series of reactions feeding first into fumarate and then malate. This shunt is 212 important not only to replenish malate and subsequently citrate (to complete the cycle) but also to 213 produce NO and IL-6, both necessary for appropriate activation of macrophages [50] . 214
Ischaemia reperfusion (IR) also causes the specific accumulation of succinate and 215 subsequent production of mitochondrial ROS. Production of ROS during ischaemia reperfusion has 216 always been thought to be a nonspecific response due to reperfusion; however, a recent study 217 demonstrates that succinate accumulation during reperfusion of ischaemic tissues is a selective 218 response that drives the generation of ROS responsible for tissue damage [52] . Using an in vivo 219 model of ischaemia in combination with unsupervised metabolomics analysis, succinate was found 220 to specifically accumulate during ischaemia in different tissues (liver, kidney, heart and brain) and it 221 was rapidly re-oxidized during reperfusion. To assess the source of succinate, they performed stable 222
isotope tracing experiments and found that succinate derived mainly from the malate/aspartate 223 shuttle (MAS) and the purine nucleotide cycle (PNC) (Figure 3 ). These two pathways led to the 224 accumulation of fumarate which was then converted to succinate by the reversal of SDH. During 225 reperfusion the accumulated succinate was rapidly re-oxidized to fumarate by SDH, leading to a 226 massive production of mROS, mainly superoxide (Figure 3 3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65 In addition to these intracellular non-metabolic effects of succinate, it also binds to a specific 230 receptor localized onto the cytoplasmic membrane, which suggests it can signal as an extracellular 231 molecule ( Figure 3) . The succinate receptor, GPR91 (also known as SUCNR), is a G protein-coupled 232 receptor whose activation triggers intracellular calcium release and inhibits cAMP production. In 233 mouse, it is expressed mainly in the kidney, liver, spleen and small intestine Mice with a T cell-specific deletion of tumour necrosis factor (TNF) receptor-associated 252 factor 6 (TRAF6) displayed a profound defect in CD8 + memory T cell generation, and were unable to 253 upregulate FAO after growth factors withdrawal during contraction phase of immune response. 254 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64 activation of AMPK with metformin was able to rescue both FAO and the generation of CD8 + 256
TRAF6-deficient CD8 + T cells exhibited defective AMP-activated kinase (AMPK) activation, whereas 255

memory T cells, suggesting TRAF6 regulates a metabolic switch towards FAO important for 257 generation of long-lived CD8 + memory T cells [54]. Regulatory CD4 + T cells (Tregs) have also been 258
shown to rely primarily on FAO during their development [55, 56] . Naturally occurring Tregs display 259 low levels of Glut1, and thus low rates of glycolysis, while having increased activation of AMPK. 260 Treatment with etomoxir, an inhibitor of carnitine palmitoyl transferase (CPT1), the rate limiting 261 enzyme in FAO, was sufficient to abrogate Treg development, suggesting that FAO is essential for 262
Treg development [55] . 263
Interestingly, it has recently been demonstrated that the increase in FAO in memory CD8 + T is 264 surprisingly the direct result of de novo FAS, rather than uptake of fatty acids from the extracellular 265 environment [57] . After observing no increase in extracellular fatty acid uptake, the authors showed 266 that extracellular glucose fuels mitochondrial fatty acid oxidation and oxidative phosphorylation 267 (OXPHOS) indicating that fatty acids are synthesised for subsequent oxidation. Upon treatment with 268 a fatty acid synthase inhibitor, memory T cell death increased suggesting fatty acid synthesis is 269 necessary for their survival. Memory T cells lack typical fatty acid storage droplets; instead, 270 lysosomal acid lipase (LAL) activity plays a role in non-classical fatty acid storage. LAL is required for 271 lipolysis of stored fatty acids to generate available fatty acids for oxidation and necessary for 272 memory T cell survival. These data support the phenomenon known as fatty acid "futile cycling" 273 whereby intracellular fatty acids are catabolized rather than acquired from extracellular sources, for 274 use in the mitochondria for fatty acid oxidation. With no net gain of ATP, this cycling of fatty acids is 275 bio-energetically redundant. However, it has been suggested that fatty acid cycling in memory T cells 276 may provide a mechanism to maintain their survival and, sustaining their glycolytic and 277 mitochondrial metabolism, may enable rapid recall responses after antigen recognition. 278
Extracellular signalling by IL-7 and IL-15 has been shown to impact on T cell development by 279 affecting FAO [58, 59] (Figure 4) . The cytokine IL-15, which is critical for the development and 280 maintenance of CD8 + memory cells, enhanced the expression of the rate-limiting FAO enzyme CPT1, 281 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64 and thus FAO. Importantly, blocking CPT1 with etomoxir impaired the mitochondrial spare 282 respiratory capacity (see Glossary) and survival of CD8 + memory T cells. Conversely, over-expression 283 of CPT1 increased the formation of CD8 + memory T cells following infection [58] . IL-7 is known to 284 control CD8 + memory T cell longevity and homeostasis [60, 61] . Recent findings demonstrate a new 285 pathway in which IL-7 promotes survival via glycerol import, triglyceride synthesis and storage. 286
Triglycerides are synthetized combining glycerol-3-phosphate and Acyl-CoAs (free fatty acids 287 activated with a Coenzyme-A moiety), thus the amount of glycerol affects triglyceride synthesis. In 288 this study IL-7 was shown to induce expression of the glycerol channel aquaporin 9 (AQP9), which 289 was required for long term survival of CD8 + memory cells. AQP9 deficiency resulted in impaired 290 glycerol import, and thus esterification of fatty acids and reduced triglyceride synthesis and storage. 291 whether FAO metabolites may have direct effects on the cell fate decision of T cells. However, a 298 recent paper has shown that long chain acyl-CoAs, which are the activated form of free fatty acids 299 and represent the pre-step reaction for β-oxidation, can act as positive modulators of ion channels 300 and exchangers [3] . Specifically, long chain acyl-CoAs were shown to be potent activators of TRPV1 301 cation channels independently of Ca2 + , and increasing the level of long chain acyl-CoAs in intact 302 Jurkat T cells leads to a significant increase in agonist-induced Ca2 + levels. This novel mechanism 303 indicates that long chain acyl-CoAs could play an active role in T cell functions under both 304 physiological and pathophysiological conditions that alter fatty acid transport and metabolism. 305
Acetyl-CoA, the end product of FAO, has also been implicated to have roles beyond the TCA 306 cycle, as it can also act as a substrate for post-translational modifications such as acetylation [62]. 307 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64 One potential mechanism is through histone acetylation, which is known to be important for 308 promoting gene transcription. In the context of immune cells, CD8 + T cells histone acetylation occurs 309 at specific loci and may be involved in determining the decision between memory and short-lived 310 effector cell fate [63] . Similarly, different histone acetylation patterns have been shown in CD4 + 311 effector T cells compared to CD4 + Tregs. Specifically, in Tregs there is increased acetylation of the 312 Foxp3 locus [64], whereas in T effector cells the IL-13, IL-15 and IL-4 loci have all been shown to have 313 increased acetylation induced by IL-4 [65] . 314 315
Concluding remarks 316 317
The discovery of extra-metabolic functions of metabolic enzymes (referred to as moon-318 lighting) has been the first evidence that metabolism and its players have a role in the regulation of 319 signalling pathways inside cells. Here, we have described how a similar concept applies to 320 metabolites, which for decades were considered to be only the building blocks of biomasses. The 321 observation that intermediates and end products of the main metabolic pathways can desert their 322 metabolic roles to function, in certain circumstances, as transduction signals shows how these 323 molecules can play an active and crucial role in regulating some of the most important biological 324 processes. We currently have evidence that some metabolites play roles in the immune and 325 inflammatory responses, and influence cytokine production, proliferation and angiogenesis, both in 326 physiology and pathology. It remains to be established if other metabolites might display similar 327
functions. 328
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REDOX STATE 382
The cellular redox state is often described as the balance of reduced and oxidized glutathione 383 (GSH/GSSG), Nicotinamidedinuclotide (NAD + /NADH) and Nicotinamidedinuclotide-phosphate 384 (NADP + /NADPH). These redox couples are central mediators for catabolic and anabolic reactions 385 acting as cofactors and regulators for enzymes, scavengers for reactive oxygen species or substrates 386 for the mitochondrial electron transport chain. 387
FUMARATE HYDRATASE (FH): 388
The TCA cycle enzyme responsible for the conversion of fumarate to malate. 389
SPARE RESPIRATORY CAPACITY: 390
The extra capacity available in cell to produce energy via mitochondrial respiration .  391   392   393   1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63 Succinate can also regulate proteins activity via succinylation. During ischaemia, fumarate 413 accumulates through the malate-aspartate shuttle (MAS) and the purine nucleotide cycle (PNC) and 414 is converted into succinate by succinate dehydrogenase reversal (SDH); during reperfusion, the rapid 415 re-oxidation of succinate to fumarate by SDH leads to the production of mitochondrial reactive 416 oxygen species (mROS) responsible for tissue damage. Furthermore, succinate in the extracellular 417 microenvironment can signal through its receptor (GPR91), sustaining cytokine production and 418 migration of dendritic cells (DC). TCA, tricarboxylic acid cycle; AMP, adenosine monophosphate; IMP, 419 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64 inosine monophosphate; PHD, prolyl hydroxylases; GABA, γ-aminobutyric acid; IR, ischeamia-420 reperfusion. 421 422 Figure 4 -Fatty acids oxidation and its role in signalling. FAO has been shown to be necessary for 423 CD8+ memory T cells survival and CD4+ regulatory T cells induction. Moreover, upregulation of 424 glycerol transporter AQP9 by cytokines is important to increase triglycerides synthesis and thus FAO. 425
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